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Growth restriction before and after birth increases
kinase signaling pathways in the adult rat heart
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1Department of Physiology, The University of Melbourne, Parkville, Victoria, Australia
2Centre for Physical Activity and Nutrition Research, School of Exercise and Nutrition Sciences, Deakin University, Burwood, Victoria,
Australia
3Institute of Sport, Exercise and Active Living and the School of Biomedical and Health Sciences, Victoria University, Victoria, Australia
To investigate the mechanisms for the previously reported development of adult cardiac hypertrophy in male rats following growth restriction,
the levels of oxidative stress and activation of signaling kinases were measured in the left ventricle (LV) of adult rat offspring. In experiment
one, bilateral uterine vessel ligation to induce uteroplacental insufficiency and growth restriction in the offspring (Restricted) or sham surgery
was performed during pregnancy. Litters from sham mothers had litter size either reduced (Reduced Litter), which also restricted postnatal
growth, or were left unaltered (Control). In males, Reduced Litter offspring had increased LV phosphorylation of AMPKa, p38 MAPK and
Akt compared with Restricted and Controls (P, 0.05). In females, both Restricted and Reduced Litter adult offspring had increased LV
phosphorylation of p38 MAPK and Akt, however, only Restricted offspring had increased phosphorylation of AMPKa (P, 0.05). In addition,
only Restricted male offspring displayed LV oxidative stress (P, 0.05). Experiment two investigated in mothers exposed to uteroplacental
insufficiency or sham surgery the effects of cross-fostering offspring at birth, and therefore the effects of the postnatal lactational environment.
Surprisingly, the cross-fostering itself resulted in increased LV phosphorylation of AMPKa and Akt in females and increased phosphorylation
of Akt in males compared with Control non-cross-fostered offspring (P, 0.05). In conclusion, kinase signaling in the adult LV can be
programmed by uteroplacental insufficiency induced growth restriction in a gender-specific manner. In addition, the heart of adult rats is also
sensitive to programming following the postnatal intervention of cross-fostering alone as well as by postnatal growth restriction.
Received 2 August 2010; Revised 27 September 2010; Accepted 20 October 2010; First published online 19 November 2010
Key words: development, cardiac muscle, kinases, foetal programming
Introduction
Babies who are thin or light at birth are much more likely to
develop cardiovascular disease, hypertension, insulin resis-
tance and type 2 diabetes as adults.1–3 The early postnatal
environment also independently influences the risk of adult
diseases, with lower infant weight gain in the first year of
life increasing the risk of adult cardiovascular disease4,5 and
accelerated weight gain after the first year of life further
increasing the risk of adult cardiovascular disease in those of
low birth weight.4 In humans, uteroplacental insufficiency is
the major cause of foetal growth restriction in the western
world.1–3 Our group, and others, have found in adult rats that
restriction of growth in prenatal life induced by uteroplacental
insufficiency adversely impacts on later cardiovascular and
metabolic health including increased rates of hypertension,6–8
cardiac hypertrophy,8 myocardial insulin resistance9 and glucose
intolerance10 as well as reducing skeletal muscle mitochondrial
biogenesis.11
In the heart, the functions of the signaling kinases AMP-
activated protein kinase (AMPK), the serine/threonine kinase
Akt (otherwise known as protein kinase B), p38 mitogen acti-
vated protein kinase (p38 MAPK), extracellular signal regulated
kinases (ERK1 and 2) and c-Jun N-terminal kinases (JNK1, 2
and 3) are yet to be fully defined, but include the regulation of
cardiac hypertrophy, apoptosis, remodeling, gene transcription,
protein synthesis and glucose uptake.12–20 Given the well-
described effects of prenatal and postnatal growth restriction on
cardiovascular health,6–9 many of the signaling kinases involved
in the regulation of these processes are likely to be altered in the
adult heart following growth restriction. Indeed, phosphoryla-
tion of Akt is upregulated in the adult rat heart in models of
growth restriction that involve maternal and postnatal under-
nutrition21 and maternal dexamethasone exposure.22 However,
the impact of growth restriction on the phosphorylation of
Akt in the adult rat heart using a model of uteroplacental
insufficiency, which is more relevant to the western world, is
not known. Surprisingly, no study of growth restriction has
investigated the impact of growth restriction on the phos-
phorylation of AMPK, p38 MAPK and JNK in the adult heart.
Oxidative stress has been implicated in the pathogenesis
of left ventricular hypertrophy23,24 and is implicated in the
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cardiac remodeling of adult female rats exposed to the
low maternal sodium exposure growth restriction model.25
Furthermore, reactive oxygen species activate AMPK, p38
MAPK and Akt in the heart26 and these kinases are impli-
cated in the development of cardiac hypertrophy.20,23,27
Therefore, we propose that the elevated oxidative stress and
subsequent phosphorylation of AMPK, p38 MAPK and Akt
may be a molecular mechanism to explain our previous
findings of prenatal and postnatal growth restriction pro-
gramming left ventricular hypertrophy in adult male rats.8
However, the level of oxidative stress in the hearts of
adult rats that were exposed to growth restriction by uter-
oplacental insufficiency has not previously been reported.
Thus, this study investigated the effect of uteroplacental
insufficiency on the signaling pathways (phosphorylated
AMPK, p38 MAPK, ERK, JNK and Akt) that are responsive
to oxidative stress and are implicated in the development
of cardiac hypertrophy in the left ventricle (LV) of adult
offspring.
Since, we have previously shown that reductions in litter size
independently programs postnatal growth restriction and
hypertension in males,8,28 all comparisons were made between
offspring of sham operated controls of normal litter size
(Controls) and a separate group of postnatal growth restriction
induced by reduced litter size, which underwent sham surgery
(termed Reduced Litter), to litters exposed to uteroplacental
insufficiency (termed Restricted), who have prenatal and post-
natal growth restriction. Importantly, we also studied male and
female offspring separately due to the marked sex differences in
a range of metabolic and cardiovascular outcomes following
uteroplacental insufficiency.6,10,11
We have previously shown that improving postnatal
nutrition and growth by cross-fostering growth-restricted
pups onto a different sham operated mother with normal
lactation prevents or ameliorates a number of adverse out-
comes including the adult onset of hypertension, nephron
deficit6 and glucose intolerance.10,29 Thus, it is possible that
cross-fostering may also ameliorate any dysregulated kinase
signaling in the adult rat heart following growth restriction.
Therefore, another aim of this study was to examine, if any
dysregulated kinase signaling in the LV of adult rats following
prenatal or postnatal growth restriction could be ameliorated
by cross-fostering.
We hypothesized, based on elevated Akt signaling in other
models of growth restriction21,22 and the aforementioned
relationships between oxidative stress, signaling kinases and
cardiac hypertrophy,20,23,24,26,27 that prenatal and postnatal
growth restriction would increase phosphorylation of AMPK,
p38 MAPK, ERK, JNK and Akt and this would be associated
with elevated levels of oxidative stress. Furthermore, based
on our previous findings that cross-fostering can ameliorate
adverse outcomes such as hypertension, nephron deficit
and glucose intolerance,6,10,29 we hypothesized that cross-
fostering would ameliorate any dysregulated kinase signaling
in the LV of prenatal or postnatal growth-restricted rats.
Methods
Animals
All experiments were approved by The University of Melbourne
Animal Experimentation Sub-Committee. Wistar Kyoto rats
(9–13 weeks of age) were obtained from the Australian
Resource Centre (Murdoch, Western Australia) prior to mating.
On day 18 of gestation, pregnant rats underwent bilateral
uterine vessel (artery and vein) ligation to induce growth
restriction, as previously described6,28,30 or sham surgery, which
was identical except the uterine vessels were not ligated.
Experiment 1: uteroplacental insufficiency
and reduced litter size
The male rats in this experiment were the same animals that
were used in our previous study describing the impact of
growth restriction on hypertension, left ventricular hyper-
trophy and nephron development.8 Importantly, the female
rats in this experiment were subject to the same conditions
at the same time as the male rats. Refer to Figure 1 for a
schematic representation of the experimental model. Briefly,
at birth, half of the litters from the sham surgery group (litter
size 10–14 pups) had their litter size randomly reduced to five
pups (Reduced Litter) to match the litter size of approxi-
mately five pups born to uteroplacentally restricted mothers
(Restricted).6,28 The remaining half of the litters from the
sham surgery were left with a normal litter size of 10–14 pups
(Control). All pups were handled at similar times and in the
same manner and remained with their own mothers until
weaning at 5 weeks of age. For all groups, 7–8 offspring of
each sex were studied, each arising from different mothers. At
6 months of age, male and female rats were killed with an
intraperitoneal injection of xylazine (30mg/kg) and ketamine
(225mg/kg). The heart was quickly dissected and the weights
of the whole heart and LV were recorded, frozen in liquid N2
and stored at 2808C.
Experiment 2: cross-fostering
The rats in this cross-fostering experiment were the same
animals that were used in our previous studies describing the
impact of growth restriction on hypertension and nephron
development in adulthood.6,29,31 Refer to Figure 1 for
a schematic representation of this experimental model.
Briefly, male and female pups from each of the three groups
described above (Control, Reduced Litter and Restricted)
were cross-fostered at day 1 onto a different control or
restricted mother as previously described.6,10 This procedure
produced six groups (pup-on-mother): Control-on-Control,
Control-on-Restricted, Reduced-on-Restricted, Reduced-on-
Control, Restricted-on-Control, Restricted-on-Restricted
with a similar number of male and female pups in each litter.
At 6 months of age, rats were killed and the LV was excised,
weighed, frozen in liquid N2 and stored at 2808C.
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Immunoblotting
For immunoblotting, frozen LV was homogenized and ana-
lyzed as previously described.11 Antibodies for phospho-p38
Thr180Tyr182 MAPK (pThr180Tyr182 p38 MAPK), AMPKa
PAN (a1 and a2 subunits), phospho-Akt Ser473 (pSer473 Akt),
phospho-Thr202Tyr204 ERK1/2 (pThr202Tyr204 ERK1/2) and
phospho Thr183Tyr185 JNK (pThr183Tyr185 JNK) were from
Cell Signaling Technology (Hartsfordshire, England). Binding
was detected with IRDyeTM 800-conjugated anti-rabbit IgG
(Rockland, Gilbertsville, PA, USA) or IRDyeTM 680-
conjugated anti-mouse IgG (Molecular Probes, Eugene, OR)
fluorescent antibodies via infrared detection (Odyssey Imaging
system, LI-COR Biosciences, Lincoln, NE). Membranes were
then stripped (2% SDS (w/v) in 25mM glycine, pH 2.0) and
re-probed with antibodies for phospho-AMPKa Thr172
(pThr172 AMPKa from Upstate Biotechnology (NY, USA)
and Akt, p38 MAPK, ERK1/2 and JNK from cell signaling.
For this study, all phosphorylation is expressed relative to
protein abundance.
Validation of tissue harvesting for measurement
of kinase phosphorylation
Since the LVs in our study were harvested for weighing prior
to being frozen, it is possible that the time taken (,2min) to
freeze the cardiac tissue may have resulted in a hypoxic/
ischemic stress. Indeed, myocardial AMPK is activated by
ischemia and anoxia.32,33 Therefore, as an important control,
we subsequently performed a validation experiment to
Fig. 1. Schematic representation of the experimental models. On day 18 of gestation, pregnant rats underwent bilateral uterine vessel
ligation (BUVL) to induce growth restriction or sham surgery (Sham). In experiment 1, at birth, half of the litters from the Sham group
(10–14 pups/l) had their litter size randomly reduced to five pups (Reduced Litter) to match the litter size of approximately five pups
born to uteroplacentally restricted mothers (Restricted). The remaining half of the litters from the Sham were left with a normal litter size
of 10–14 pups (Control). In experiment 2, pups from each of the three groups described above (Control (Con), Reduced Litter (Red) and
Restricted (Res)) were cross-fostered at day 1 onto a different control or restricted mother. This procedure produced six groups (pup-on-
mother). For both experiments, the rats were killed at the age of 6 months.
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examine the phosphorylation of these kinases and the metabolite
levels at a range of time points following dissection. Male rats
from sham surgery groups at 5 weeks of age were anaesthetized
with an intraperitoneal injection of xylazine (30mg/kg) and
ketamine (225mg/kg). Once pedal reflexes were lost, the chest
cavity was quickly opened and while the heart was still beating,
it was freeze-clamped while still in the chest or dissected, blotted
free of blood and left at room temperature before being freeze-
clamped immediately (i.e. 661 s of dissection) and 60, 180
and 300 s following dissection (n56 rats per time point).
Hearts were crushed into a powder under liquid N2 and stored
at 2808C for later measurement of metabolites and kinase
phosphorylation as previously described.34 We examined whole-
hearts (rather than LV), since this was the quickest method to
extract and freeze cardiac muscle.
Five minutes delay in freezing did not significantly increase
cardiac pThr172 AMPKa, pSer473 Akt, pThr183Tyr185 JNK, the
ratio of free AMP/ATP or levels of creatine, nor did it sig-
nificantly decrease cardiac levels of ATP, creatine phosphate
or glycogen (data not shown). The cardiac ATP levels and ratio
of free AMP/ATP for all timepoints were (mean6 S.E.M.)
13.26 0.6mmol/kg dry weight and 0.676 0.12, respectively,
and are consistent with normal non-ischemic myocardial levels
that have been previously reported.33,35,36 Thus, the , 2min
of delayed freezing in this study does not induce a significant
ischemic or hypoxic stress on cardiac tissue. Similar findings of
no change in high-energy phosphates in pig cardiac muscle with
delays in freezing for up to 5min have also been reported.37
However, in this study, a delay in freezing time of 60 to 300 s
significantly increased cardiac pThr180Tyr182 p38 MAPK,
pThr202Tyr204 ERK1/2 and lactate levels (P, 0.05, data not
shown).
The relatively stable levels of high-energy phosphates and
the lack of increase in pThr172 AMPKa during 5min of
delayed freezing is likely due to the dramatically reduced
energy demand of the myocardium following dissection in
our validation study when compared to the energy demands
of isolated perfused and contracting hearts subjected to
ischemia and anoxia.32,33,36 Therefore, any differences in
pThr172 AMPKa, pSer473 Akt and pThr183Tyr185 JNK that
we observe between growth-restricted groups cannot, there-
fore, be an artifact of harvesting methodology.
Oxidative stress
The ratio of oxidized to total glutathione (GSSG/TGSH) is a
commonly used marker of intracellular oxidative stress38,39
and was measured using a commercially available kit
(Biooxytech GSH/GSSG-412, Oxis Health Products, Portland,
USA) as described by Sandstrom et al.38
Statistical analyses
Results were analyzed using one-way ANOVA, with Newman–
Keuls post hoc analysis, where appropriate. All data are
presented as mean6 S.E.M. The level of significance was set
at P, 0.05.
Results
Experiment 1: effect of uteroplacental insufficiency and
postnatal growth restriction (Reduced Litter) on heart
mass and LV kinase phosphorylation and oxidative stress
Briefly, the adult female Restricted and Reduced Litter and
adult male Restricted litter offspring had reduced body weight
compared with Controls (Table 1) as previously described.11
Furthermore, we have previously shown that these male
Restricted and Reduced Litter offspring have left ventricular
hypertrophy and hypertension,8 while for adult females blood
pressure is not altered.8
Table 1. Experiment 1: the effect of uteroplacental insufficiency (Restricted) and reducing litter size (Reduced Litter) on body
and heart weight in adult offspring
Control Reduced Litter Restricted
Female
Body weighta (g) 2316 4 2156 6* 2136 3*
Heart weight (% of body weight) 0.396 0.01 0.396 0.01 0.386 0.01
LV weight (% of heart weight) 72.16 2.6 69.66 2.8 70.26 3.2
Male
Body weighta (g) 3676 7 3526 5 3296 9*,**
Heart weightb (% of body weight) 0.376 0.01 0.346 0.01 0.346 0.02
LV weightb (% of heart weight) 67.76 2.1 78.56 1.6* 75.06 2.6*
LV5 left ventricle.
Values are mean6 S.E.M.; n5 10 per group for Control and Reduced Litter and n5 8 for Restricted.
a Body weights of both sexes have been previously reported.11
bHeart weights of the adult male offspring have been previously reported.8
*P, 0.05 v. Control; **P, 0.05 v. Reduced Litter.
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For adult female rats, this study found LV hypertrophy was
not evident, since there was no significant difference in heart
weight or LV weight between Control, Reduced Litter or
Restricted rats, respectively (Table 1).
In females
Restricted adult offspring had increased pThr172 AMPKa
(P, 0.05; Fig. 2) compared to Controls. In addition,
AMPKa protein abundance was significantly lower in the
Restricted and Reduced Litter offspring compared to Controls
(P, 0.05, 0.996 0.08 and 0.946 0.06 compared to
1.176 0.05 integrated intensity, respectively). However, the
altered AMPKa protein abundance had no influence on
the higher pThr172 AMPKa in Restricted adult offspring, as
the effect was observed with or without normalization to
AMPKa protein (data not shown). Both Restricted and
Reduced Litter adult offspring had increased pThr180Tyr182
p38 MAPK and pSer473 Akt (P, 0.05; Fig. 2). Protein
abundance of p38 MAPK and Akt was not altered between
groups in the LV. There was no significant difference between
the female offspring in LV pThr202Tyr204 ERK1/2 and
pThr183Tyr185 JNK (data not shown). However, ERK 1/2
protein abundance was significantly lower in the Reduced Litter
compared to Controls and Restricted offspring (P,0.05,
23.260.6 compared to 28.460.7 and 25.560.9 integrated
intensity, respectively). Protein abundance of JNK was not
altered between groups in the LV (data not shown). LV levels of
oxidative stress were unaltered (Table 2).
In males
Reduced Litter offspring had increased pThr172 AMPKa,
pThr180Tyr182 p38 MAPK and pSer473 Akt compared to
Control and Restricted (P, 0.05; Fig. 2). Protein abundance
of AMPKa, p38 MAPK and Akt were not altered between
groups. There was no significant difference between the male
offspring in pThr202Tyr204 ERK1/2 and pThr183Tyr185 JNK
or ERK 1/2 and JNK protein abundance (data not shown). In
addition, Restricted offspring had significantly increased
oxidative stress in the LV compared to Reduced Litter off-
spring (P, 0.05; Table 2).
Fig. 2. Experiment 1: The effect of uteroplacental insufficiency (Restricted) and reducing litter size (Reduced Litter) on LV
phosphorylation of AMPKa Thr172 (pThr172 AMPKa), p38 MAPK Thr180Tyr182 (pThr180Tyr182 p38 MAPK) and Akt Ser473 (pSer473
Akt) in adult female (left) and male (right) offspring. Western blots are representative from one rat from each treatment group. Values are
mean6 S.E.M.; n5 8 for all groups, except n5 7 for male and female Restricted groups. *P, 0.05 v. Control; LV5 left ventricle.
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Experiment 2: the effect of cross-fostering and prenatal
and postnatal growth restriction on LV kinase
phosphorylation and oxidative stress
In females
All cross-fostered groups had significantly increased (approxi-
mately twofold) pThr172 AMPKa and pSer473 Akt compared
to Control (non-cross-fostered) offspring (P,0.05, Fig. 3).
In addition, the pThr180Tyr182 p38 MAPK was significantly
higher in the Con-on-Res and Res-on-Con offspring compared
to the Controls (P, 0.05; Fig. 3). The pThr172 AMPKa,
pThr180Tyr182 p38 MAPK and pSer473 Akt were not sig-
nificantly different across these six cross-fostered groups even
when a separate ANOVA was performed on these groups.
In addition, protein abundance of AMPKa, p38 MAPK and
Akt were not significantly different between any of the female
groups (data not shown).
In males
All cross-fostered groups had significantly increased pSer473
Akt compared to Control offspring (P, 0.05; Fig. 3).
Red-on-Con offspring had significantly higher pSer473 Akt
compared to Red-on-Res (P, 0.05; Fig. 3). In addition,
the pThr180Tyr182 p38 MAPK was significantly higher in the
Con-on-Con and Con-on-Res offspring compared to the
Controls (P, 0.05; Fig. 3). Furthermore, p38 MAPK and
Akt protein abundance was significantly lower in the Control
offspring compared to all six cross-fostered groups (P, 0.05,
data not shown). Protein abundance of AMPKa was not
significantly different between any of the male groups (data
not shown).
Discussion
A major finding of this study was that early life perturbations
of both uteroplacental insufficiency and restriction of post-
natal growth by reductions in litter size, increased kinase
signaling in the LV of adult female rats, while only reducing
litter size and therefore postnatal growth restriction induced
similar increases in male offspring. Another major finding was
that compared to non-cross-fostered animals, the cross-fostering
intervention exerts its own effects on the programming of
kinase phosphorylation levels in the adult rat heart.
Oxidative stress is known to be an activator of AMPK, p38
MAPK and Akt in the heart26 and is implicated in the
pathogenesis of cardiovascular hypertrophy and remodel-
ing.23,24 However, it is unlikely oxidative stress is responsible
for the programming of LV hypertrophy we have previously
observed in these male Restricted and Reduced Litter adult
offspring,8 since only the Restricted offspring displayed
increased oxidative stress (Table 2). Furthermore, although
this study found uteroplacental insufficiency programs oxi-
dative stress in the LV of Restricted male offspring, this does
not account for the altered kinase signaling we observed in the
males, since the increased pThr172 AMPKa, pThr180Tyr182
p38 MAPK and pSer473 Akt were only observed in the
Reduced Litter and not the Restricted males. Since oxidative
stress increases with ageing in the heart,40 it is possible that the
oxidative stress observed in the male Restricted offspring at
6 months of age could have a much greater impact on cardio-
vascular health in much older rodents and further studies are
required to examine this. Nevertheless, it would appear that the
mechanism for the LV hypertrophy we have previously
observed in these male Restricted and Reduced Litter rats8 is
probably occurring independently of oxidative stress.
The functions of AMPK, p38 MAPK and Akt signaling in
the heart are yet to be fully defined, but include the regulation
of gene transcription, protein synthesis, apoptosis, cardio-
myocyte hypertrophy and glucose uptake.12–17 However, the
collective pattern of activation/phosphorylation of AMPK,
p38 MAPK and Akt in the heart often differs depending on
which of these pathways one is considering. For example,
elevated cardiomyocyte hypertrophy in the adult heart is
largely consistent with increased phosphorylation of Akt,15
but reduced phosphorylation of AMPK12 and p38 MAPK.16
Anti-apoptotic signaling in the cardiomyocyte is also largely
consistent with increased phosphorylation of AMPKa14 and
Akt,14 but decreased p38 MAPK phosphorylation.17 How-
ever, the consequences of increased phosphorylation of
AMPK, p38 MAPK and Akt in the heart all include increased
glucose uptake.12–14 Therefore, the largely consistent pattern
of increased pThr172 AMPKa, pThr180Tyr182 p38 MAPK
and pSer473 Akt in the LV of male and female Reduced Litter
and female Restricted rats in this study tends to suggest a
role for increased basal (non-insulin-stimulated) glucose
uptake in the myocardium of these rats. Further work is now
required to establish whether the elevated myocardial kinase
Table 2. Experiment 1: the effect of uteroplacental insufficiency (Restricted) and reducing litter size (Reduced Litter) on left
ventricle oxidative stress in adult female and male offspring
Control Reduced Litter Restricted
Female (ratio: GSSG/TGSH) 0.0316 0.003 0.0396 0.005 0.0326 0.003
Male (ratio: GSSG/TGSH) 0.0326 0.005 0.0256 0.003 0.0406 0.001*
Values are mean6 S.E.M.; n5 5 per group for females and n5 7 per group for males.
*P, 0.05 v. Reduced Litter (one-way ANOVA).
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signaling following prenatal and postnatal growth restriction
in this study is also consistent with elevated basal heart
glucose uptake.
AMPK has been implicated in altering substrate utilization
during pressure overload hypertrophy.35 However, increased
pThr172 AMPKa (Fig. 2) was found in the adult male off-
spring of Reduced Litters only, whereas we have previously
reported that both these adult male Reduced Litter and
Restricted offspring have hypertension and left ventricular
hypertrophy.8 We also found increased pThr172 AMPKa
(Fig. 2) in the Restricted adult female offspring despite
unaltered left ventricular mass and blood pressure.8
This would suggest that the altered LV AMPK signaling
we observed in Reduced Litter males and Restricted females
is occurring independently from the hypertension and left
ventricular hypertrophy previously observed in both these
male growth-restricted groups.8
An important finding of this study was that reduced
postnatal growth as a consequence of reduced litter size
increases LV kinase signaling in adult female offspring inde-
pendently of uteroplacental insufficiency. Similarly, we have
previously shown reduced postnatal growth via reductions in
litter size exerts its own influence on the metabolic char-
acteristics of adult skeletal muscle.11 The mechanism(s)
whereby an adverse postnatal environment can program later
kinase signaling in heart and metabolic function in skeletal
muscle are unclear, but are likely to include altered postnatal
nutrition, due to the reduced quantity and altered composi-
tion of maternal milk.28 Moderate reductions of litter size
is also commonly used in many studies to control for the
reduced number of pups following intrauterine growth
restriction.41–44 It is important to note that if we had used the
Reduced Litter group as the only control in this study, we
would have reported impaired pThr172 AMPKa, pThr180Tyr182
Fig. 3. Experiment 2: The effect of uteroplacental insufficiency (Restricted: Res) and reducing litter size (Reduced Litter: Red) and cross-
fostering on LV phosphorylation of AMPKa Thr172 (pThr172 AMPKa), p38 MAPK Thr180Tyr182 (pThr180Tyr182 p38 MAPK) and Akt
Ser473 (pSer473 Akt) in adult female (left) and male (right) offspring. Western blots are representative from one rat from each group.
Values are mean6 S.E.M.; n5 10 for all groups except n5 8 for Control group (CON). *P, 0.05 v. CON, 1P, 0.05 v. Red-on-Res.
For pThr172 AMPKa in males, P5 0.12 (one-way ANOVA); LV5 left ventricle.
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p38 MAPK and pSer473 Akt in the male Restricted group
(v. Reduced Litter; Fig. 2), rather than normal phosphorylation
of these variables. Importantly, pups from Control, Restricted
and Reduced Litter groups were all handled identically after
birth, so our findings cannot be due to the stress on the mothers
or pups caused by differences in handling. Thus, our present
finding in the LV and previous findings in skeletal muscle11
highlight the importance of including additional controls with
unaltered litter size when investigating the impact of growth
restriction in cardiac and skeletal muscle.
A surprising finding was that prenatal and postnatal growth
restriction impacted the LV kinase signaling of adult female rats
more than male rats, as evidenced by elevated pSer473 Akt and
pThr180Tyr182 p38 MAPK in both Restricted and Reduced
litter groups while males only displayed these elevated levels
in the Reduced Litter group. Consistent with these findings,
estrogen is known to increase pSer473 Akt in the heart.45
Furthermore, estrogen protects against the development of adult
hypertension in the female growth-restricted rat.46 Thus, it is
possible that these protective effects of estrogen in the female
growth-restricted heart may have secondary consequences, such
as the altered kinase signaling we have observed in the LV.
Further experiments are now required to examine the possible
role of estrogen on our gender-specific findings.
Cross-fostering is commonly used in growth restriction
studies to control or manipulate postnatal nutrition.6,10,42,44,47
It was concerning, therefore, that we found cross-fostering
alone exerts effects on the programming of the rat heart, with
pSer473 Akt, pThr172 AMPKa and pThr180Tyr182 p38 MAPK
either significantly higher or tending to be higher in the LV
of all cross-fostered groups of both male and female rats
compared to Control non-cross-fostered animals (Fig. 3).
Importantly, the effects of cross-fostering on LV kinase phos-
phorylation were minimal within the cross-fostered groups
when compared to the Control (non-cross-fostered) offspring.
These findings highlight the importance of adequate control
groups for the interpretation of results and demonstrate the
vulnerability of the early postnatal heart to programming from
stresses related to cross-fostering alone (i.e. a control pup cross-
fostered onto a different control mother). Indeed, maternal
care such as the levels of licking and grooming provided by
the mother is known to program altered gene expression in
the brain of adult rat offspring,48 including genes in the
MAPK pathway,49 although its effects on the heart remain to
be elucidated.
In conclusion, increased pThr172 AMPKa, pThr180Tyr182
p38 MAPK and pSer473 Akt can be programmed by utero-
placental insufficiency in a gender-specific manner in the
adult rat LV. Surprisingly, the LV of adult rats is sensitive to
postnatal growth restriction following reductions in litter size
and also the postnatal intervention of cross-fostering alone.
However, these results together with our previous studies
suggest that the activation of these kinase signaling pathways
by growth restriction occurs independently of high blood
pressure,8 ventricular hypertrophy8 or oxidative stress.
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